Abstract:Previously, we established for the first time an in vivo monitoring assay system conjugated with random mutagenesis in order to study the structure-function relationship of the antimicrobial peptide, apidaecin [Taguchi et al. (1996) Appl. Environ. Microbiol. 62, 4652-4655]. In the present study, this methodology was used to carry out the functional mapping of a second target, thanatin, a 21-residue peptide that exhibits the broadest antimicrobial spectrum so far observed among insect defense peptides [Fehlbaum et al. (1996) Proc. Natl. Acad. Sci. USA 93, 1221-1225]. First, a synthetic gene encoding thanatin was expressed in a fused form with Streptomyces protease inhibitor protein, SSI, under the control of tac promoter in Escherichia coli JM109. Expression of the thanatin-fused protein was found to depend on the concentration of the transcriptional inducer, isopropyl-beta-D-thio-galactopyranoside (IPTG), and to parallel the degree of growth inhibition of the transformant cells. When a PCR random mutation was introduced into the structural gene for thanatin, diminished growth inhibition of the IPTG-induced transformed cells was mostly observed in variants as measured by colony size (plate assay) or optical density (liquid assay) in comparison with the wild-type peptide, possibly depending on the decreased antimicrobial activity of each variant. Next, wild-type thanatin and three variants screened by the in vivo assay, two singly mutated proteins (C11Y and M21R) and one doubly mutated protein (K17R/R20G), were stably overproduced with a fusion partner protein resulting in the efficient formation of inclusion bodies in E. coli BL21(DE3). The products were isolated in large amounts (yield 30%) from the fused protein by successive chemical and enzymatic digestions at the protein fusion linker site. Anti-E. coli JM109 activities, judged by minimum inhibitory concentration, of the purified peptides were in good agreement with those estimated semi-quantitatively by the in vivo assay. Based on the NMR solution structure and molecular dynamics, the structure-function relationship of thanatin is discussed by comparing the functional mapping data obtained here with the previous biochemical data. The functional mapping newly suggests the importance of a hydrogen bonding network formed within the C-terminal loop joining the beta-strands arranged antiparallel to one another that are supposed to be crutial for exhibiting anti-E. coli activity.

Expression and Purification of Antimicrobial Peptide s-Thanatin in Escherichia coli

Expression and Purification of Antimicrobial Peptide S-thanatin in Escherichia Coli and Effects of Different MIC Identification Methods on It

Application of Immobilized Thrombin for Production of S-thanatin Expressed in Escherichia Coli

Expression and Purification of Thanatin Mutant in E.coli

Design, Expression and Characterization of Recombinant Hybrid Peptide Attacin-Thanatin in Escherichia Coli

Expression and Purification of an Antimicrobial Peptide, Bovine Lactoferricin Derivative LfcinB-W10 in Escherichia Coli

Functional mapping against Escherichia coli for the broad-spectrum antimicrobial peptide, thanatin, based on an in vivo monitoring assay system

Recombinant Expression of Antimicrobial Peptides Using a Novel Self-Cleaving Aggregation Tag Inescherichia Coli

Determination of a new antibacterial peptide S-thanatin in rat plasma by an indirected-ELISA.

Soluble Expression of Antimicrobial Peptide BSN-37 from Escherichia coli by SUMO Fusion Technology

Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli

High-level Expression,Purification and Activity of the Plectasin

High Efficient Expression and Purification of the Escherichia Coli T-protein

Fusion Expression and Bacteriostatic Activity in Vivo of Hybrid Peptide Attacin-Thanatin

Thanatin: A Promising Antimicrobial Peptide Targeting the Achilles' Heel of Multidrug-Resistant Bacteria

Expression and Purification of Two Different Antimicrobial Peptides, PR-39 and Protegrin-1 in Escherichia Coli.

Recombinant expression of a novel antimicrobial peptide consisting of human α-defensin 5 and Mytilus coruscus mytilin-1 in Escherichia coli

Design and high-level expression of a hybrid antimicrobial peptide LF15-CA8 in Escherichia coli

Expression of Thanatin Inschizosaccharomyces Pombe

Activity, Interactions, and Structures of Thanatin Derived Antimicrobial Peptides

Recombinant expression, purification, and antimicrobial activity of a novel hybrid antimicrobial peptide LFT33